Your browser doesn't support javascript.
loading
Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network.
Heard, Jean-Michel; Vrinten, Charlotte; Schlander, Michael; Bellettato, Cinzia Maria; van Lingen, Corine; Scarpa, Maurizio.
Afiliación
  • Heard JM; MetabERN, Regional Coordinating Center for Rare Diseases, Udine University Hospital, Piazzale Santa Maria della Misericordia, 15, 33100, Udine, Italy. jean-michel.heard@metab.ern-net.eu.
  • Vrinten C; Imperial College Business School, London, UK.
  • Schlander M; Division of Health Economics, German Cancer Research Center, Heidelberg, Germany.
  • Bellettato CM; MetabERN, Regional Coordinating Center for Rare Diseases, Udine University Hospital, Piazzale Santa Maria della Misericordia, 15, 33100, Udine, Italy.
  • van Lingen C; MetabERN, Regional Coordinating Center for Rare Diseases, Udine University Hospital, Piazzale Santa Maria della Misericordia, 15, 33100, Udine, Italy.
  • Scarpa M; MetabERN, Regional Coordinating Center for Rare Diseases, Udine University Hospital, Piazzale Santa Maria della Misericordia, 15, 33100, Udine, Italy.
Orphanet J Rare Dis ; 15(1): 3, 2020 01 06.
Article en En | MEDLINE | ID: mdl-31907071
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Producción de Medicamentos sin Interés Comercial / Enfermedades Metabólicas / Errores Innatos del Metabolismo Idioma: En Revista: Orphanet J Rare Dis Asunto de la revista: MEDICINA Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Producción de Medicamentos sin Interés Comercial / Enfermedades Metabólicas / Errores Innatos del Metabolismo Idioma: En Revista: Orphanet J Rare Dis Asunto de la revista: MEDICINA Año: 2020 Tipo del documento: Article